PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.
- DOI
- 10.1038/s41416-026-03607-7
- Published
- 2026 Sep 4
- Container
- British journal of cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41416-026-03607-7,
title = {PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.},
author = {Hirano H and Yamada Y and Nagashima K and Hiraoka N and Sekine S and Takahashi N and Azuma M and Iwasa S and Kanato K and Machida N and Kinoshita T and Hata H and Kawakami H and Takahari D and Ojima T and Kadowaki S and Boku N and Kurokawa Y and Terashima M and Yoshikawa T},
year = {2026},
journal = {British journal of cancer},
doi = {10.1038/s41416-026-03607-7},
url = {https://doi.org/10.1038/s41416-026-03607-7}
}RIS
TY - JOUR TI - PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1. AU - Hirano H AU - Yamada Y AU - Nagashima K AU - Hiraoka N AU - Sekine S AU - Takahashi N AU - Azuma M AU - Iwasa S AU - Kanato K AU - Machida N AU - Kinoshita T AU - Hata H AU - Kawakami H AU - Takahari D AU - Ojima T AU - Kadowaki S AU - Boku N AU - Kurokawa Y AU - Terashima M AU - Yoshikawa T PY - 2026 JO - British journal of cancer DO - 10.1038/s41416-026-03607-7 UR - https://doi.org/10.1038/s41416-026-03607-7 ER -
APA
H, H., Y, Y., K, N., N, H., S, S., N, T., M, A., S, I., K, K., N, M., T, K., H, H., H, K., D, T., T, O., S, K., N, B., Y, K., M, T., & T, Y. (2026). PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.. British journal of cancer. https://doi.org/10.1038/s41416-026-03607-7
Source records
- pubmed · retrieved 2026-09-25T23:57:37.919Z